From pricing pressure to performance: Rewiring Pharma & Biotech workforces for an evergreen future
Learn from experts at Accenture and Orgvue and how pricing reform, AI, and margin compression are reshaping operating models, skills, and workforce strategy across life sciences.
Pharmaceutical and biotechnology companies are facing a fundamental reset. From most favored nation pricing policies and global margin compression to supply chain resilience and AI-driven transformation, the rules of the game are changing fast.
In this webinar, leaders from Accenture and Orgvue explore how these macro forces are reshaping operating models, organizational design, and workforce strategy. Discover why pricing is breaking down silos, how companies are centralizing strategy while streamlining execution, and what it takes to build an “evergreen” organization ready for continuous change.
Learn practical steps to reduce complexity, increase transparency into work and skills, and build the transformation muscle needed to thrive in a more intentional, data-driven future.
Viewers will gain practical insights into how to:
- Redesign operating models under pricing pressure
- Reduce complexity before scaling AI
- Shift from reactive transformation to continuous change
- Align skills strategy with commercial and scientific impact
Watch now to learn what it takes to build “evergreen” workforce planning capabilities that evolve roles, skills, and structures in real time.
Meet the experts
Amalia Stein, Senior Account Manager, Orgvue
More about Amalia
Amalia is on the North America Account Management team at Orgvue, helping our clients drive business outcomes, backed by the power of Orgvue.
Amalia works with enterprise clients to help them navigate the complexities of large-scale transformation, especially as AI reshapes how work is structured and delivered. With a background in financial planning and a focus on aligning Workforce Planning and Organizational Design, she helps organizations unlock the full value of data-driven organization design. Her work empowers leaders to make faster, smarter design decisions that position their organizations for long-term success in a rapidly changing world.
Cherene Powell, Managing Director, Accenture Strategy
More about Cherene
Cherene Powell is a Managing Director with Accenture Strategy. She partners with C-suite leaders to architect broad-based reinvention in service of activating the business strategy. She has held various Global and North America leadership roles spanning strategy, thought leadership, and business operations
Cherene has 20+ years of consulting experience working with Fortune 1000 clients to define strategy and execute reinvention agendas. Her areas of expertise include: strategy activation, enterprise and multi-function operating model and organization design, architecting ambitious operating expense reduction agendas, as well as the necessary adaptation of talent and culture to drive change in support of achieving strategy for growth and competitive differentiation. Cherene has advised and partnered with 50+ companies – including multiple Fortune10 – across multiple industries including (but not limited to) pharmaceuticals, medical devices, consumer goods and services, retail, energy, communications, media, and software & platforms.
As the current North America Lead of Accenture’s Operating Model and Organization Design practice, Cherene leads Accenture’s go-to-market activities, which includes the integration of Kates Kesler methodologies and expertise, which Accenture acquired in 2020. In addition to serving as a frequent keynote speaker and subject matter expert at industry forums, Cherene has published topics related to new operating models, the promise of new technological advancements and the implication to workforce and culture, and the intersection of business and psychology. This includes FORTUNE, CFO.com, CFO Magazine, Accenture.com, and the book “Rethinking Operating Models”.
Cherene has been externally recognized as an influential business leader including being named as a 2016 industry Luminary by the Healthcare Businesswomen’s Association, as a Young Global Leader (YGL) by the World Economic Forum (WEF), which she attended the annual gathering in Davos, Switzerland, an Accenture delegate in 2025.
Cherene graduated from the College of St. Benedict / St. John’s University with a double degree in Political Science and Communication. She has continued her higher education with programs at Northwestern Kellogg School of Business, the University of Chicago-Booth, and MIT.
Shikha Tyagi, Managing Director, Accenture Strategy
More about Shikha
Shikha is a Managing Director leading our offerings in Life Sciences Enterprise Operating Model and Organisation Design across EMEA. She brings deep pharmaceutical industry experience and a strong understanding of the end-to-end pharma value chain, spanning R&D, clinical development, regulatory, manufacturing, quality, supply chain, commercial, medical affairs, market access, and enabling functions. Shikha has extensive experience working with FTSE 100 and global life sciences companies to shape the right organisation strategy and deliver organisational change in a way that balances risk and growth priorities while driving meaningful behavioural change across people and organisations. She has a strong track record of leading cross-geographic, multi-disciplinary operating model design, transformation, activation, implementation, and transition programmes, as well as culture and leadership change. Shikha holds an MBA in Finance and International Business and a Bachelor’s degree in Engineering.